Indivior Pharmaceuticals (INDV) Change in Account Payables (2022 - 2024)
Historic Change in Account Payables for Indivior Pharmaceuticals (INDV) over the last 3 years, with Q4 2024 value amounting to -$24.0 million.
- Indivior Pharmaceuticals' Change in Account Payables fell 20000.0% to -$24.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $48.0 million, marking a year-over-year decrease of 5826.09%. This contributed to the annual value of $48.0 million for FY2024, which is 5826.09% down from last year.
- Indivior Pharmaceuticals' Change in Account Payables amounted to -$24.0 million in Q4 2024, which was down 20000.0% from $4.0 million recorded in Q3 2024.
- In the past 5 years, Indivior Pharmaceuticals' Change in Account Payables ranged from a high of $55.0 million in Q2 2024 and a low of -$46.0 million during Q3 2022
- Moreover, its 3-year median value for Change in Account Payables was $18.5 million (2023), whereas its average is $9.4 million.
- As far as peak fluctuations go, Indivior Pharmaceuticals' Change in Account Payables soared by 20434.78% in 2023, and later crashed by 20000.0% in 2024.
- Quarter analysis of 3 years shows Indivior Pharmaceuticals' Change in Account Payables stood at -$23.0 million in 2022, then surged by 204.35% to $24.0 million in 2023, then tumbled by 200.0% to -$24.0 million in 2024.
- Its Change in Account Payables was -$24.0 million in Q4 2024, compared to $4.0 million in Q3 2024 and $55.0 million in Q2 2024.